GPCR Therapeutics' Series B Round

GPCR Therapeutics raised a round of funding on October 11, 2018. Investors include Smilegate Investment.

GPCR Therapeutics (지피씨알) develops pharmaceuticals based on its G Protein-Coupled Receptor (GPCR) technology. G protein-coupled receptors (GPCRs) are cell surface receptors that transmit extrac…

Articles about GPCR Therapeutics' Series B Round: